Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities
about
The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseaseMouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII.
P2860
Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Comparison of human glutamate ...... ergent substrate specificities
@ast
Comparison of human glutamate ...... ergent substrate specificities
@en
Comparison of human glutamate ...... ergent substrate specificities
@nl
type
label
Comparison of human glutamate ...... ergent substrate specificities
@ast
Comparison of human glutamate ...... ergent substrate specificities
@en
Comparison of human glutamate ...... ergent substrate specificities
@nl
prefLabel
Comparison of human glutamate ...... ergent substrate specificities
@ast
Comparison of human glutamate ...... ergent substrate specificities
@en
Comparison of human glutamate ...... ergent substrate specificities
@nl
P2093
P2860
P356
P1433
P1476
Comparison of human glutamate ...... ergent substrate specificities
@en
P2093
Jan Tykvart
Jiří Schimer
Lubomír Rulíšek
Michal Navrátil
Petr Pachl
Tibor András Rokob
Václav Navrátil
P2860
P304
P356
10.1111/FEBS.13761
P407
P577
2016-06-06T00:00:00Z